Exchange: NASDAQ·Updated 07:39 PM EDT
INMB logo

INMB INmune Bio Inc

$2.44
$0.17
(7.49%)
Today
Closed $2.44
$0.002
(0.08%)
After Hours
EarningsOct 29
Mkt Cap$67.72M
Vol323,961.00

About INMB

INmune Bio, Inc. is a clinical stage biotechnology company, which engages in developing new immunotherapies that reprogram the immune system to fight cancer and Alzheimer’s disease. The company was founded by Mark Lowdell on September 25, 2015 and is headquartered in Boca Raton, FL.
33

Bearish Sentiment

How do you feel about INMB?

Advertisement|Remove ads.